MENU
+Compare
FBIO
Stock ticker: NASDAQ
AS OF
Apr 4, 12:00 PM (EDT)
Price
$1.47
Change
-$0.05 (-3.29%)
Capitalization
41.96M

FBIO Fortress Biotech Forecast, Technical & Fundamental Analysis

Fortress Biotech Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for FBIO with price predictions
Apr 03, 2025

FBIO sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for FBIO moved below the 200-day moving average on February 28, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FBIO as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for FBIO turned negative on March 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at .

FBIO moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBIO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FBIO entered a downward trend on March 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FBIO's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where FBIO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FBIO advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .

FBIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.846) is normal, around the industry mean (13.581). P/E Ratio (0.000) is within average values for comparable stocks, (64.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.548) is also within normal values, averaging (248.206).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FBIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FBIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

FBIO is expected to report earnings to fall 76.86% to -21 cents per share on March 27

Fortress Biotech FBIO Stock Earnings Reports
Q4'23
Est.
$-0.22
Q3'23
Beat
by $2.27
Q2'23
Beat
by $0.16
Q1'23
Missed
by $0.01
Q4'22
Missed
by $0.08
The last earnings report on November 14 showed earnings per share of -93 cents, beating the estimate of -321 cents. With 97.86K shares outstanding, the current market capitalization sits at 41.96M.
A.I. Advisor
published General Information

General Information

a developer of novel immunotherapy biologic agents

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1111 Kane Concourse
Phone
+1 781 652-4500
Employees
186
Web
https://www.fortressbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAIC114.26-1.44
-1.24%
Science Applications International Corp
JD39.90-1.19
-2.90%
JD.com
ASRV2.37-0.08
-3.27%
AmeriServ Financial
WLFC151.59-8.98
-5.59%
Willis Lease Finance Corp
ADV1.31-0.14
-9.66%
Advantage Solutions

FBIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
-5.59%
AXON - FBIO
38%
Loosely correlated
-3.35%
CRBP - FBIO
37%
Loosely correlated
-5.38%
ABOS - FBIO
35%
Loosely correlated
-8.52%
QSI - FBIO
32%
Poorly correlated
-5.69%
AVIR - FBIO
32%
Poorly correlated
+0.69%
More